Pin-Nan Cheng, Ph.D

Sr Dir, Drug Substance Development, CMC at Altimmune

Speaker

Pin-Nan Cheng, PhD is a Senior Director of Drug Development at Altimmune developing Pemvidutide for liver and cardiometabolic diseases, where he leads drug substance CMC for peptide therapeutics, spanning route/process development, analytical strategy, control strategy, scale-up, tech transfer, and regulatory submissions. With a foundation in organic and peptide chemistry and broad experience across small molecules, peptides, and oligonucleotide-adjacent platforms, he partners closely with internal teams and CDMOs to deliver robust, phase-appropriate manufacturing solutions and CMC strategies. Before Altimmune, he worked at Bachem, a leading peptide and oligonucleotide CMOD as a process R&D director for ~ 5 years. Pin-Nan is recognized for human-centric leadership—building high-performing, collaborative teams while advancing quality, safety, and green chemistry principles. He has 17 high-impact publications and significant global experience across U.S. and international organizations.